Tau is the major component of neurofibrillary tangles (NFTs); therefore, antibodies against Tau and NFTs have allowed the characterization of the pathogenesis of neurofibrillary tangles (NFTs) in Alzheimer disease (EA). This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.